What we are studying
Multicenter, randomized, double-blind, placebo-controlled study designed to determine the effect of treatment with setipiprant tablets 1000 mg BID on scalp hair growth. The study is approximately 32 weeks long with participants being randomized into one of three groups: Group taking Setipiprant tablets 1000mg BID, Group taking placebo BID, or Group taking Finasteride 1mg once/day. The three groups will take their regimens for 24 weeks. Eligible non-PK subjects will be randomly assigned to all three groups. PK subjects will be randomly assigned to either the setipiprant tablets or placebo groups. There are 7 scheduled study visits.
$50 for Each Completed Visit or a Total of $350